Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 20:14 UTC |
Eckler Matthew JosephDirector
|
GrantStock Option (right to buy) · Derivative | 84,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0002156044-26-000004 · form4-10052026_081058.xml · derivative · entry 1 Eckler Matthew Joseph · CIK 0002156044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2036-10-01 F1 · derivative.exercise_date: Shares subject to the option vest in 36 equal monthly installments beginning on November 1, 2026. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:30 UTC |
LEVINE ARNOLD JDirector
|
GrantStock Option (right to buy) · Derivative | 42,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001124164-26-000002 · form4-06052026_080603.xml · derivative · entry 1 LEVINE ARNOLD J · CIK 0001124164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2036-06-04 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:23 UTC |
FLOWERS KIRSTENDirector
|
GrantStock Option (right to buy) · Derivative | 42,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001797209-26-000002 · form4-06052026_080614.xml · derivative · entry 1 FLOWERS KIRSTEN · CIK 0001797209 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2036-06-04 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:25 UTC |
Gallagher Carol GiltnerDirector
|
GiftStock Option (right to buy) · Derivative | 42,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001329959-26-000002 · form4-06052026_080616.xml · derivative · entry 3 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2036-06-04 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. F2 · ownership.nature: The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:25 UTC |
Gallagher Carol GiltnerDirector
|
GiftStock Option (right to buy) · Derivative | 42,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001329959-26-000002 · form4-06052026_080616.xml · derivative · entry 2 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,000 shares Expires 2036-06-04 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:25 UTC |
Gallagher Carol GiltnerDirector
|
GrantStock Option (right to buy) · Derivative | 42,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001329959-26-000002 · form4-06052026_080616.xml · derivative · entry 1 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2036-06-04 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:20 UTC |
BAUM CHARLES MDirector
|
GrantStock Option (right to buy) · Derivative | 42,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001579824-26-000003 · form4-06052026_080642.xml · derivative · entry 1 BAUM CHARLES M · CIK 0001579824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2036-06-04 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:32 UTC |
Stelzer LaurieDirector
|
GrantStock Option (right to buy) · Derivative | 42,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001644348-26-000003 · form4-06052026_080643.xml · derivative · entry 1 Stelzer Laurie · CIK 0001644348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2036-06-04 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 16:41 UTC |
Carulli MichaelChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 240,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0002006668-26-000002 · form4-03092026_080319.xml · derivative · entry 2 Carulli Michael · CIK 0002006668 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,000 Underlying: Common Stock · 240,000 shares Expires 2036-03-05 F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on April 5, 2026. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 16:35 UTC |
Mack David HenryDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 744,960 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001341642-26-000002 · form4-03092026_080314.xml · derivative · entry 1 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 744,960 Underlying: Common Stock · 744,960 shares Expires 2036-03-05 F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on April 5, 2026. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 16:39 UTC |
Ticktin RobertGeneral Counsel & COO
|
GrantEmployee Stock Option (right to buy) · Derivative | 319,270 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001613482-26-000002 · form4-03092026_080354.xml · derivative · entry 1 Ticktin Robert · CIK 0001613482 · General Counsel & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 319,270 Underlying: Common Stock · 319,270 shares Expires 2035-03-05 F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2026. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:36 UTC |
Jalota DeepikaChief Development Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 303,310 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001825192-26-000002 · form4-03092026_080350.xml · derivative · entry 1 Jalota Deepika · CIK 0001825192 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,310 Underlying: Common Stock · 303,310 shares Expires 2036-03-05 F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on April 5, 2026. Read SEC document |
| October 27, 2025 Filed Oct 29, 2025 16:11 UTC |
Mack David HenryDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 220,643 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001341642-25-000004 · form4-10292025_081048.xml · derivative · entry 5 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 220,643 shares Expires 2026-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document |
| October 27, 2025 Filed Oct 29, 2025 16:11 UTC |
Mack David HenryDirector · President and CEO
|
Exercise / conversionCommon Stock | 220,643 | $1.37 | $302,280.91 |
DisclosureSEC source: 0001341642-25-000004 · form4-10292025_081048.xml · nonDerivative · entry 1 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 451,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Excludes 305,667 shares previously reported as held directly by the reporting person which were re-registered on August 13, 2025 and are now held of record by the Mack-Mulligan Revocable Trust (the "Revocable Trust"). Read SEC document |
| October 23, 2025 Filed Oct 27, 2025 21:19 UTC |
ORBIMED ADVISORS LLC10% owner
OrbiMed Capital GP V LLC10% owner
|
SaleCommon Stock | 1,000,000 | $1.52 | $1,520,000.00 |
DisclosureSEC source: 0000947871-25-000927 · ownership.xml · nonDerivative · entry 1 ORBIMED ADVISORS LLC · CIK 0001055951 · 10% owner OrbiMed Capital GP V LLC · CIK 0001615374 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 4,975,291 F1 · ownership.nature: These securities are held of record by OrbiMed Private Investments V, LP ("OPI V"). OrbiMed Capital GP V LLC ("GP V") is the general partner of OPI V, and OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment advisor under the Investment Advisors Act of 1940, as amended, is the managing member of GP V. By virtue of such relationships, GP V and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI V. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI V. F2 · ownership.nature: This report on Form 4 is jointly filed by OrbiMed Advisors and GP V. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1943, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 21:09 UTC |
ORBIMED ADVISORS LLC10% owner
OrbiMed Capital GP V LLC10% owner
|
SaleCommon Stock | 500,000 | $1.80 | $900,000.00 |
DisclosureSEC source: 0000947871-25-000854 · ownership.xml · nonDerivative · entry 1 ORBIMED ADVISORS LLC · CIK 0001055951 · 10% owner OrbiMed Capital GP V LLC · CIK 0001615374 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 5,975,291 F1 · ownership.nature: These securities are held of record by OrbiMed Private Investments V, LP ("OPI V"). OrbiMed Capital GP V LLC ("GP V") is the general partner of OPI V, and OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment advisor under the Investment Advisors Act of 1940, as amended, is the managing member of GP V. By virtue of such relationships, GP V and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI V. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI V. F2 · ownership.nature: This report on Form 4 is jointly filed by OrbiMed Advisors and GP V. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1943, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 19:49 UTC |
Carulli MichaelChief Financial Officer
|
SaleCommon Stock | 28,249 | $1.06 | $30,076.71 |
DisclosureSEC source: 0001415889-25-019382 · form4-07032025_110716.xml · nonDerivative · entry 1 Carulli Michael · CIK 0002006668 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,146 F1 · shares: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 19:48 UTC |
Mack David HenryDirector · President and CEO
|
SaleCommon Stock | 58,411 | $1.06 | $62,178.51 |
DisclosureSEC source: 0001415889-25-019380 · form4-07032025_110757.xml · nonDerivative · entry 1 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 536,133 F1 · shares: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · balance_after: Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 19:51 UTC |
Ticktin RobertGeneral Counsel & COO
|
SaleCommon Stock | 23,151 | $1.06 | $24,651.18 |
DisclosureSEC source: 0001415889-25-019386 · form4-07032025_110750.xml · nonDerivative · entry 1 Ticktin Robert · CIK 0001613482 · General Counsel & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,695 F1 · shares: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · balance_after: Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 23:50 UTC |
Jalota DeepikaChief Development Officer
|
SaleCommon Stock | 33,065 | $1.06 | $35,197.69 |
DisclosureSEC source: 0001415889-25-019384 · form4-07032025_110708.xml · nonDerivative · entry 1 Jalota Deepika · CIK 0001825192 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,959 F1 · shares: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:27 UTC |
LEVINE ARNOLD JDirector
|
GrantStock Option (right to buy) · Derivative | 33,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001415889-25-016269 · form4-06092025_080646.xml · derivative · entry 1 LEVINE ARNOLD J · CIK 0001124164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,500 Underlying: Common Stock · 33,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:22 UTC |
FLOWERS KIRSTENDirector
|
GrantStock Option (right to buy) · Derivative | 33,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001415889-25-016259 · form4-06092025_080616.xml · derivative · entry 1 FLOWERS KIRSTEN · CIK 0001797209 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,500 Underlying: Common Stock · 33,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:23 UTC |
Gallagher Carol GiltnerDirector
|
GiftStock Option (right to buy) · Derivative | 33,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001415889-25-016262 · form4-06092025_080644.xml · derivative · entry 3 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 33,500 Underlying: Common Stock · 33,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. F2 · ownership.nature: The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:23 UTC |
Gallagher Carol GiltnerDirector
|
GiftStock Option (right to buy) · Derivative | 33,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001415889-25-016262 · form4-06092025_080644.xml · derivative · entry 2 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:23 UTC |
Gallagher Carol GiltnerDirector
|
GrantStock Option (right to buy) · Derivative | 33,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001415889-25-016262 · form4-06092025_080644.xml · derivative · entry 1 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,500 Underlying: Common Stock · 33,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:20 UTC |
BAUM CHARLES MDirector
|
GrantStock Option (right to buy) · Derivative | 33,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001415889-25-016254 · form4-06092025_080615.xml · derivative · entry 1 BAUM CHARLES M · CIK 0001579824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,500 Underlying: Common Stock · 33,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:26 UTC |
Heyman Richard A.Director
|
GrantStock Option (right to buy) · Derivative | 33,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001415889-25-016266 · form4-06092025_080655.xml · derivative · entry 1 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,500 Underlying: Common Stock · 33,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:30 UTC |
Stelzer LaurieDirector
|
GrantStock Option (right to buy) · Derivative | 33,500 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001415889-25-016276 · form4-06092025_080633.xml · derivative · entry 1 Stelzer Laurie · CIK 0001644348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,500 Underlying: Common Stock · 33,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 18:34 UTC |
Carulli MichaelChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 265,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001415889-25-007075 · form4-03052025_110309.xml · derivative · entry 1 Carulli Michael · CIK 0002006668 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,000 Underlying: Common Stock · 265,000 shares Expires 2035-03-03 F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 18:30 UTC |
Mack David HenryDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 800,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001415889-25-007071 · form4-03052025_110346.xml · derivative · entry 5 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2035-03-03 F5 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:32 UTC |
Jalota DeepikaChief Development Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001415889-25-007073 · form4-03052025_110323.xml · derivative · entry 2 Jalota Deepika · CIK 0001825192 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2035-03-03 F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025. Read SEC document |
| January 03, 2025 Filed Jan 22, 2025 16:37 UTC |
Mack David HenryDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,709 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001415889-25-001853 · form4-01222025_090129.xml · derivative · entry 7 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,709 shares Expires 2025-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document |
| January 03, 2025 Filed Jan 22, 2025 16:37 UTC |
Mack David HenryDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,709 | $0.53 | $9,385.77 |
DisclosureSEC source: 0001415889-25-001853 · form4-01222025_090129.xml · nonDerivative · entry 2 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 551,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2024 Filed Jan 22, 2025 16:37 UTC |
Mack David HenryDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 91,750 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001415889-25-001853 · form4-01222025_090129.xml · derivative · entry 6 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,709 Underlying: Common Stock · 91,750 shares Expires 2025-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document |
| December 03, 2024 Filed Jan 22, 2025 16:37 UTC |
Mack David HenryDirector · President and CEO
|
Exercise / conversionCommon Stock | 91,750 | $0.53 | $48,627.50 |
DisclosureSEC source: 0001415889-25-001853 · form4-01222025_090129.xml · nonDerivative · entry 1 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 534,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2024 Filed Sep 12, 2024 17:59 UTC |
Carulli MichaelChief Financial Officer
|
SaleCommon Stock | 2,891 | $1.50 | $4,346.91 |
DisclosureSEC source: 0001415889-24-023309 · form4-09122024_090908.xml · nonDerivative · entry 1 Carulli Michael · CIK 0002006668 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,395 F1 · kind: These reported shares were sold to cover the reporting person's tax obligation in connection with the vesting of restricted stock units, or RSUs. Read SEC document |
| September 11, 2024 Filed Sep 12, 2024 22:00 UTC |
Jalota DeepikaChief Development Officer
|
SaleCommon Stock | 7,218 | $1.50 | $10,852.98 |
DisclosureSEC source: 0001415889-24-023313 · form4-09122024_100948.xml · nonDerivative · entry 1 Jalota Deepika · CIK 0001825192 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,283 F1 · kind: The reported shares were sold to cover the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 16:48 UTC |
Carulli MichaelChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | Not disclosed Strike: $1.48 | Not disclosed |
DisclosureSEC source: 0001415889-24-024624 · form4-10032024_081040.xml · derivative · entry 5 Carulli Michael · CIK 0002006668 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-08-13 F7 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 75,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 75,000 shares, having an exercise price of $1.48 per share. F8 · derivative.exercise_date: One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 16:48 UTC |
Carulli MichaelChief Financial Officer
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 75,000 | Not disclosed Strike: $5.70 | Not disclosed |
DisclosureSEC source: 0001415889-24-024624 · form4-10032024_081040.xml · derivative · entry 4 Carulli Michael · CIK 0002006668 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-05-12 F7 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 75,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 75,000 shares, having an exercise price of $1.48 per share. F6 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on June 12. 2023. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 16:48 UTC |
Carulli MichaelChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 40,805 | Not disclosed Strike: $1.48 | Not disclosed |
DisclosureSEC source: 0001415889-24-024624 · form4-10032024_081040.xml · derivative · entry 3 Carulli Michael · CIK 0002006668 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,805 Underlying: Common Stock · 40,805 shares Expires 2034-08-13 F2 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 13,605 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 13,605 shares, having an exercise price of $1.48 per share. F4 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 27,200 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 27,200 shares, having an exercise price of $1.48 per share. F5 · derivative.exercise_date: One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 16:48 UTC |
Carulli MichaelChief Financial Officer
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 27,200 | Not disclosed Strike: $16.29 | Not disclosed |
DisclosureSEC source: 0001415889-24-024624 · form4-10032024_081040.xml · derivative · entry 2 Carulli Michael · CIK 0002006668 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,200 shares Expires 2032-02-10 F4 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 27,200 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 27,200 shares, having an exercise price of $1.48 per share. F3 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 16:48 UTC |
Carulli MichaelChief Financial Officer
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 13,605 | Not disclosed Strike: $28.33 | Not disclosed |
DisclosureSEC source: 0001415889-24-024624 · form4-10032024_081040.xml · derivative · entry 1 Carulli Michael · CIK 0002006668 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,605 shares Expires 2031-05-12 F2 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 13,605 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 13,605 shares, having an exercise price of $1.48 per share. F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 16:44 UTC |
Mack David HenryDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 330,000 | Not disclosed Strike: $1.48 | Not disclosed |
DisclosureSEC source: 0001415889-24-024622 · form4-10032024_081002.xml · derivative · entry 5 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,000 Underlying: Common Stock · 330,000 shares Expires 2034-08-13 F7 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 330,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 330,000 shares, having an exercise price of $1.48 per share. F8 · derivative.exercise_date: One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 16:44 UTC |
Mack David HenryDirector · President and CEO
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 330,000 | Not disclosed Strike: $5.70 | Not disclosed |
DisclosureSEC source: 0001415889-24-024622 · form4-10032024_081002.xml · derivative · entry 4 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 330,000 shares Expires 2033-05-12 F7 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 330,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 330,000 shares, having an exercise price of $1.48 per share. F6 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 16:44 UTC |
Mack David HenryDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 384,184 | Not disclosed Strike: $1.48 | Not disclosed |
DisclosureSEC source: 0001415889-24-024622 · form4-10032024_081002.xml · derivative · entry 3 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 384,184 Underlying: Common Stock · 384,184 shares Expires 2034-08-13 F2 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 134,584 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 134,584 shares, having an exercise price of $1.48 per share. F4 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 249,600 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 249,600 shares, having an exercise price of $1.48 per share. F5 · derivative.exercise_date: One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 16:44 UTC |
Mack David HenryDirector · President and CEO
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 249,600 | Not disclosed Strike: $16.29 | Not disclosed |
DisclosureSEC source: 0001415889-24-024622 · form4-10032024_081002.xml · derivative · entry 2 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 249,600 shares Expires 2032-02-10 F4 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 249,600 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 249,600 shares, having an exercise price of $1.48 per share. F3 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 16:44 UTC |
Mack David HenryDirector · President and CEO
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 134,584 | Not disclosed Strike: $28.33 | Not disclosed |
DisclosureSEC source: 0001415889-24-024622 · form4-10032024_081002.xml · derivative · entry 1 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 134,584 shares Expires 2031-05-11 F2 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 134,584 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 134,584 shares, having an exercise price of $1.48 per share. F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 20:50 UTC |
Jalota DeepikaChief Development Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | Not disclosed Strike: $1.49 | Not disclosed |
DisclosureSEC source: 0001415889-24-024627 · form4-10032024_081022.xml · derivative · entry 5 Jalota Deepika · CIK 0001825192 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-03-13 F7 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 125,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 125,000 shares, having an exercise price of $1.48 per share. F8 · derivative.exercise_date: One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 20:50 UTC |
Jalota DeepikaChief Development Officer
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 125,000 | Not disclosed Strike: $5.70 | Not disclosed |
DisclosureSEC source: 0001415889-24-024627 · form4-10032024_081022.xml · derivative · entry 4 Jalota Deepika · CIK 0001825192 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2033-05-12 F7 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 125,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 125,000 shares, having an exercise price of $1.48 per share. F6 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023. Read SEC document |
| August 13, 2024 Filed Oct 3, 2024 20:50 UTC |
Jalota DeepikaChief Development Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 90,774 | Not disclosed Strike: $1.48 | Not disclosed |
DisclosureSEC source: 0001415889-24-024627 · form4-10032024_081022.xml · derivative · entry 3 Jalota Deepika · CIK 0001825192 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,774 Underlying: Common Stock · 90,774 shares Expires 2034-08-13 F2 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 22,674 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 22,674 shares, having an exercise price of $1.48 per share. F4 · price: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 68,100 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 68,100 shares, having an exercise price of $1.48 per share. F5 · derivative.exercise_date: One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.